FDA.reportPublic FDA data

Beta-haemolytic Group B Streptococcus antigen IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of antigens from Group B beta-haemolytic Streptococcus bacteria in a clinical specimen.
GUDID devices
1
Last updated
2019-04-02 01:32:13

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
00884883006386Acrometrix GBS Positive ControlMicrogenics Corporation9600412018-09-07